Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-07

FDA Approved: ESLICARBAZEPINE ACETATE — Original Application (Apotex Corp.)

View source ↗

Summary

FDA approved Apotex Corp.'s original ANDA for eslicarbazepine acetate, a generic anticonvulsant, for use as adjunctive therapy in adults with partial-onset seiz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • eslicarbazepine acetate (eslicarbazepine acetate)

Snippet

ORIG AP for ESLICARBAZEPINE ACETATE (ESLICARBAZEPINE ACETATE)